Purchase of Own Securities

UNITED DRUG PLC

('United Drug' or 'the Company')

Purchase of Own Securities

United Drug announces that on 2 June 2011, its broker Davy purchased 47,500 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.265 per share.

The 47,500 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 242,746,167 to 242,698,667. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

Ends 3 June 2011

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720